News

Tuesday, June 13th, 2017

CONTINUUS Team meets FDA

The CONTINUUS Team has met with key FDA representatives for a progress update on the implementation of our end-to-end Integrated Continuous Manufacturing (ICM) process.  The picture below includes (from the left) Sap Chattopadhyay, Stephen Born, Salvatore Mascia, Bayan Takizawa, Vida…
Thursday, February 16th, 2017

CONTINUUS looking to hire a full-time Financial Administrative Accountant

CONTINUUS Pharmaceuticals is looking to hire a Financial Administrative Accountant to work full-time at our offices in Woburn, MA.  To learn more about this position and its requirements, please see:  CONTINUUS Pharmaceuticals_Job Post for Financial Administrative Accountant.…
Wednesday, February 1st, 2017

CONTINUUS Pharmaceuticals Awarded Best Italian Start-up

On January 9th, 2017 CONTINUUS CEO, Salvatore Mascia, was awarded a price for the 2017 Best Italian Start-Up abroad founded by an Italian entrepreneur.  The picture shows Salvatore receiving the award by the Italian Minister of Foreign Affairs, Angelino Alfano.…
Thursday, January 26th, 2017

CONTINUUS Pharmaceuticals enjoys successful 2016, looking forward to 2017

2016 marked a very successful year for CONTINUUS Pharmaceuticals.  The team was able to advance its innovative technology platform through work done with the National Science Foundation, as well as projects with commercial partners.  As a result, CONTINUUS was able…
Wednesday, November 16th, 2016

CONTINUUS Pharmaceuticals Awarded $4.4 M Contract with US FDA

CONTINUUS Pharmaceuticals, Inc. was recently awarded a $4.4 M contract by the US Food and Drug Administration (US FDA).  The purpose of this collaborative work, entitled “Advancement of Integrated Continuous Manufacturing (ICM) Unit Operations,” is to develop a science and…
Tuesday, November 1st, 2016

CONTINUUS Pharmaceuticals Included in C&EN’s 10 Startups to Watch

Chemical & Engineering News included CONTINUUS Pharmaceuticals in its list of “10 Startups to Watch”. To learn more, please see:  http://cen.acs.org/articles/94/i43/Continuus-Pharmaceuticals.html…
Thursday, March 31st, 2016

Breakfast Meeting with Italian Prime Minister, Matteo Renzi

Salvatore Mascia met Italian Prime Minister, Matteo Renzi at a breakfast meeting in Boston, together with 14 other young Italian entrepreneurs. During his speech to the Prime Minister, Dr. Mascia introduced CONTINUUS’s ICM technology and mentioned the ongoing collaboration with…
Wednesday, March 23rd, 2016

CONTINUUS CEO Presents to the FDA on Integrated Continuous Manufacturing

Salvatore Mascia was invited by the FDA to give a presentation on CONTINUUS’s Integrated Continuous Manufacturing Platform. Dr. Mascia discussed all of the novel continuous manufacturing technologies under development at CONTINUUS, including an end-to-end process control system (based on Delta…
Tuesday, March 1st, 2016

CONTINUUS awarded SBIR Phase II grant from the National Science Foundation

CONTINUUS Pharmaceuticals was awarded a Phase II SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase II grant consists of $750,000 over a two year period, with the opportunity for additional matching funds…
Tuesday, November 3rd, 2015

CONTINUUS secures an additional contract for a top-selling generic medication

CONTINUUS Pharmaceuticals expanded its pipeline by securing a contract with a major pharmaceutical client. CONTINUUS will implement its innovative ICM technology platform for a top-selling generic pharmaceutical.  “This represents a great opportunity for generic pharmaceutical companies. Implementing ICM will allow…
next »